NRX looks great at these levelsKey Stats
Market Cap: $14.5M
52-Week Range: $1.10 - $7.33
Short Interest: 6.68%, with days to cover at 3.51
RSI (14): 41 (leaning towards oversold territory)
Technical Reasons for Upside
Price Rejection at Key Support: NRXP has been hugging the $1.20–$1.25 range, with consistent rejection a
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.11 CAD
−6.91 M CAD
0.00 CAD
54.31 M
About NUREXONE BIOLOGIC INC
Sector
Industry
CEO
Lior Shaltiel
Website
Headquarters
Bnei-Brak
Founded
2011
FIGI
BBG002CV5Z73
NurExone Biologic, Inc. is a pharmaceutical company, which engages in the development and commercialization of biological extracellular vesicles-based technology drug platforms. It focuses on the treatment of spinal cord injury, traumatic brain injury, and other brain and neurological indications. The company was founded on June 27, 2011 and is headquartered in Bnei-Brak, Israel.
NRX - Nurexone trend analysis since bull run commencing in 2023Having a look at Nurexone trends alongside Point of Control & Ichimoku Cloud indicators. Current bullish pennant formation detected following a successful Downward Wedge.
*Next move: Trace Fibonacci retracement, indicate loss % between ATH and support levels, future projections
$NRX.V Outpaces Biotech Peers Following TSX.V Listing The biotech sector is presenting exciting opportunities for investors despite the broader downturn in global equity markets. Many of the best biotech companies and ETFs have both strong drug candidate pipelines in the works as well as winning drugs and therapeutic products already on the market. The
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of NRX is 0.64 CAD — it has increased by 3.08% in the past 24 hours. Watch NUREXONE BIOLOGIC INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange NUREXONE BIOLOGIC INC stocks are traded under the ticker NRX.
NRX stock hasn't changed in a week, the month change is a −2.90% fall, over the last year there was no change in NUREXONE BIOLOGIC INC price.
We've gathered analysts' opinions on NUREXONE BIOLOGIC INC future price: according to them, NRX price has a max estimate of 3.10 CAD and a min estimate of 3.10 CAD. Watch NRX chart and read a more detailed NUREXONE BIOLOGIC INC stock forecast: see what analysts think of NUREXONE BIOLOGIC INC and suggest that you do with its stocks.
NRX stock is 4.69% volatile and has beta coefficient of 0.031. Track NUREXONE BIOLOGIC INC stock price on the chart and check out the list of the most volatile stocks — is NUREXONE BIOLOGIC INC there?
Yes, you can track NUREXONE BIOLOGIC INC financials in yearly and quarterly reports right on TradingView.
NUREXONE BIOLOGIC INC is going to release the next earnings report on May 21, 2025. Keep track of upcoming events with our Earnings Calendar.
NRX earnings for the last quarter are −0.014 CAD per share, whereas the estimation was −0.029 CAD resulting in a 50.00% surprise. The estimated earnings for the next quarter are −0.029 CAD per share. See more details about NUREXONE BIOLOGIC INC earnings.
NUREXONE BIOLOGIC INC revenue for the last quarter amounts to 0.00 CAD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
NRX net income for the last quarter is −2.16 M CAD, while the quarter before that showed −1.70 M CAD of net income which accounts for −26.81% change. Track more NUREXONE BIOLOGIC INC financial stats to get the full picture.
No, NRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NUREXONE BIOLOGIC INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NUREXONE BIOLOGIC INC technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NUREXONE BIOLOGIC INC stock shows the buy signal. See more of NUREXONE BIOLOGIC INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.